The second issue of this program on the role of immune checkpoint inhibitors in the treatment of metastatic NSCLC without targetable alterations features a discussion with Dr Corey Langer, moderated by Dr Neil Love.

Lung Cancer Update

Oncology Today with Dr Neil Love: Role of Immune Checkpoint Inhibitors in the Management of Metastatic NSCLC without Actionable Mutations

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

About

Lung Cancer Update